Kevin earned his Ph.D. in Computational Chemistry from the University of Maryland, specializing in drug and biomaterial design through pH-related computational simulations. Following the completion of his doctoral journey, Kevin assumed the role of Director of Business Development at XtalPi. There, he adeptly orchestrated pivotal partnerships with prominent public companies across Asia and the United States to advance drug discovery endeavors. Kevin's fusion of computational chemistry prowess and shrewd business acumen has driven XtalPi's remarkable growth and triumph in the dynamic drug discovery arena.